A retrospective natural history study of patients (pts) with PDGFRα D842V mutant advanced gastrointestinal stromal tumor (GIST) previously treated with a tyrosine kinase inhibitor (TKI).

Authors

null

Margaret von Mehren

Fox Chase Cancer Center, Philadelphia, PA

Margaret von Mehren , Michael C. Heinrich , Hongliang Shi , Patrick McNamara , Khalid Kevin Mamlouk , Anthony Boral , Suzanne George

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Gastrointestinal Stromal Tumors (GIST)

Citation

J Clin Oncol 36, 2018 (suppl; abstr 11533)

DOI

10.1200/JCO.2018.36.15_suppl.11533

Abstract #

11533

Poster Bd #

278

Abstract Disclosures

Similar Posters

First Author: Steven Bialick

First Author: John Raymond Zalcberg